Aegon/$AEG

1D1W1MYTD1Y5YMAX

About Aegon

Aegon is a life insurance and long-term savings business listed in the Netherlands. It was listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. In recent years, Aegon has been moving through an extensive transformation program during which management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the company that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile earnings products and recycle capital into capital-light and more predictable strategic businesses.
Ticker
$AEG
Sector
Finance
Primary listing
NYSE
Employees
12,100

Aegon Metrics

BasicAdvanced
$13B
12.75
$0.71
0.62
$0.39
4.54%

What the Analysts think about Aegon

Analyst ratings (Buy, Hold, Sell) for Aegon stock.
Analyst projections of the future price of Aegon stock.

Bulls say / Bears say

Aegon reported strong first-half 2026 momentum: operating result rose 9% to EUR 804 million and operating capital generation increased 27% to EUR 416 million, supported by growth in Transamerica and improved claims experience. (SEC filing)
Capital returns are accelerating: Aegon raised its second-half 2026 buyback to EUR 350 million, announced an interim dividend of EUR 0.21 per share—up 11% year over year—and retained EUR 1.7 billion of cash capital at holding. (Aegon)
The planned sale of Aegon UK for £2.0 billion advances the shift toward a more focused U.S. life, annuity and retirement platform, with proceeds intended for deleveraging and shareholder returns. (Reuters)
Free cash flow excluding Aegon UK remittances was flat year over year in the first half of 2026, underscoring the challenge of replacing cash generation from the divested business. (SEC filing)
The U.S. redomiciliation, headquarters move and transition to U.S. GAAP are expected to require substantial execution effort and implementation spending; Aegon had already booked EUR 137 million of related expenses by June 2026. (SEC filing)
The Aegon UK disposal remains subject to regulatory approvals and could reduce near-term cash remittances, while the transaction also leaves Aegon exposed to the performance and valuation of its planned 15.3% Standard Life stake. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 9 Sept 2026.

Aegon Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Aegon Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.